Metis Global Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$258K	Buy	15,401 +1,749	+13%	+$29.3K	0.01%	672
2025 Q1	$210K	Sell	13,652 -45	-0.3%	-$692	0.01%	724
2024 Q4	$302K	Buy	13,697 +860	+7%	+$19K	0.01%	665
2024 Q3	$231K	Buy	12,837 +359	+3%	+$6.47K	0.01%	709
2024 Q2	$203K	Buy	+12,478	New	+$203K	0.01%	720